Owler

MAY 17, 2023

Worldia’s product and the company’s resilience impressed investors like Credit Mutuel Innovation , who led the Series B funding round. Series A Funding Round Results in $59M for Taichu Biotech A China-based provider of drug development and evaluation services for the biopharmaceutical industry, Taichu Biotech raised $59M in funds.

Biotech 52

Biotech Travel Capital Entertainment 52

Engage3

MAY 19, 2022

Ken served on the Board of Directors of Revionics between 2007-2011 and as Chief Scientist & VP of Innovations at SAP AG between 2006-2007. Tim Ouimet Founder & Board Observer Tim Ouimet is a Founder and Board Member at Engage3 and is a recognized industry innovator in retail pricing strategies.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

APRIL 19, 2024

2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion. On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. Over the past few years, the technology industry has experienced dramatic highs and lows.

Technology 69

Technology Technology Retail Due Diligence 69

Wink Intel

FEBRUARY 23, 2021

tech and biotech ETFs and two fixed income components. With a twofold focus on technology, both in its design and in its equity thematic, this innovative index aims at providing investors with an opportunity for consistent performance across various market cycles.”.

Intellectual Property 40

Intellectual Property Banking Biotech Retail 40

CIO

MARCH 4, 2025

CEOs, CIOs and CFOs are finding that deep tech is actively driving business innovation and profitability. Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products. CRISPR) for personalized medicine and drought-resistant crops.

Technology 442

Technology Technology Biotech Business 442

Alpha Sense BI

MARCH 13, 2024

According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs. In January, HATCo announced its intent to acquire Summa Health of Ohio , a non-profit healthcare system, with a focus to “put innovation in.”

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 14, 2025

The venture capital sector is poised for a long-awaited return to dealmaking, fund deployment, and exit opportunities in 2025. Data from the National Venture Capital Association (NVCA) illustrates a massive backlog in VC exits. To train these models requires so much capital that only hyperscalers are going to be able to compete today.

Capital 59

Capital Biotech Startups Finance 59

Alpha Sense BI

FEBRUARY 6, 2025

Capital Ones Acquisition of Discover Financial: $35.3 The FTC has not yet stated whether it intends to block the deal, but some Capital One customers have brought a class-action lawsuit in an attempt to block the merger. The deal would potentially reshape the U.S. Verizons Acquisition of Frontier Communications: $19.6

Biotech 59

Biotech Capital Pharmaceutical Finance 59

Alpha Sense BI

JANUARY 8, 2025

At the same time, the outlook for therapeutic innovation remains bright. RFK), have clouded 2025 visibility for the healthcare sector and generated a mix of expectations for healthcare systems and providers, health insurers, and biotech/pharma companies. Kennedy Jr. What] makes it significantly worse is how the public reacted.

Innovation 69

Innovation Biotech Pharmaceutical Benchmarking 69